F9B-15745-19810
3 vaccinations
5 coded responses
19 check-ins
5 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 51-55
- ZIP prefix
- 231 / VA
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
-
2021-03-28
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
-
2021-04-17
Dose 2 — Pfizer-BioNTech
- 2021-04-17
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Migraine, Pre-existing disease, Vomiting — Feeling: Fair · Headache, Nausea, Vomiting · Be unable to do your normal daily activitiesFree text: Started 72 hours after shot 2. Migraine that gets worse. Vomiting last nightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Survey response — day 7, dose 2MedDRA: Office visit — Feeling: Fair · Headache, Nausea, Vomiting, Diarrhea · Be unable to do your normal daily activitiesFree text: Ended up at urgent care.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — day 14, dose 2MedDRA: Emergency care, Migraine, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Severe migraine, vomiting, been to ER 2x.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-07-17
Survey response — 3 months, dose 2MedDRA: Intracranial aneurysm, Polymyalgia rheumatica — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Suffered Brain Aneurysm, and PolyMyalgia Rhuematica.MedDRA releases: 2024-11 · check-in free text available
-
2021-07-17
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-07-27
Call successfulParticipant prefers to complete VAERS report online
-
2021-08-30
Dose 3 — Pfizer-BioNTech
-
2021-10-16
Survey response — 6 months, dose 2MedDRA: Aneurysm, Emergency care, Hospitalisation, Polymyalgia rheumatica — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Since 2nd vax shot, Pfiser, I have suffered a large anuerysm, developed Polymyalgia Rhuematica and possible also Myaesthenia Gravis. I did get the booster on 8/30/2021. · Healthcare visit (other): 6 trips to ER, 4 extended hospitalizations,MedDRA releases: 2024-11 · check-in free text available
-
2021-10-16
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-10-18
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-17 | Pfizer-BioNTech | |
| 3 | 2021-08-30 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Started 72 hours after shot 2. Migraine that gets worse. Vomiting last night
Release 7 — day 7, dose 2
Systemic reaction (other): Ended up at urgent care.
Release 8 — day 14, dose 2
Symptoms: Severe migraine, vomiting, been to ER 2x.
Release 9 — 3 months, dose 2
Symptoms: Suffered Brain Aneurysm, and PolyMyalgia Rhuematica.
Release 10 — 6 months, dose 2
Symptoms: Since 2nd vax shot, Pfiser, I have suffered a large anuerysm, developed Polymyalgia Rhuematica and possible also Myaesthenia Gravis. I did get the booster on 8/30/2021.
Healthcare visit (other): 6 trips to ER, 4 extended hospitalizations,
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Emergency care | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| SD | Aneurysm | · | · | ✓ |
| SD | Emergency care | ✓ | ✓ | ✓ |
| SD | Intracranial aneurysm | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Polymyalgia rheumatica | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Office visit | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release